Error: Could not add to watchlist. X

Hemispherx Biopharma Inc

+ Watchlist
HXB:GR
Frankfurt
0.16
EUR
0.00
2.99%
As of 15:05:50 ET on 07/29/2015.
Open
0.17
Day Range
0.15 - 0.18
Volume
25,000
Previous Close
0.17
52Wk Range
0.14 - 0.36
1 Yr Return
-17.35%
Open
0.17
Day Range
0.15 - 0.18
Volume
25,000
Previous Close
0.17
52Wk Range
0.14 - 0.36
1 Yr Return
-17.35%
YTD Return
-14.74%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
39.294
Shares Outstanding (m)
242.555
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
ADDRESS
1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
PHONE
1-215-988-0080
  • William A Carter
    Chairman/Pres/CEO
  • Thomas K Equels
    Vice Chairman/CFO/Secy/Gen Cnsl
  • Adam Pascale
    Chief Acctg Officer/Controller
  • David R Strayer
    Chief Medical Ofcr/Dir:Medical
  • Wayne S Springate
    Senior VP:Operations
Show More